Cargando…
DEF6 has potential to be a biomarker for cancer prognosis: A pan-cancer analysis
INTRODUCTION: DEF6 is a gene associated with the immune system and is thought to play a crucial role in autoimmunity. There are few DEF6-related studies in cancer, and it is assumed that DEF6 is a proto-oncogene. There is currently no pan-cancer analysis of DEF6, and we performed a systematic and co...
Autores principales: | Yuan, Ziming, Zhong, Yuchen, Hu, Hanqing, Zhang, Weiyuan, Wang, Guiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848736/ https://www.ncbi.nlm.nih.gov/pubmed/36686789 http://dx.doi.org/10.3389/fonc.2022.1064376 |
Ejemplares similares
-
Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
por: Fang, Qingxiao, et al.
Publicado: (2023) -
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021) -
FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022) -
Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer
por: Zhong, Yuchen, et al.
Publicado: (2023) -
Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)